← All Topics / ade

FDA ADE reports for Maropitant (NK-1 antagonist antiemetic (Cerenia)) — total reports, species & reaction breakdown

ade_maropitant_adverse_events

ade 206 tok en 2026-07-21

Maropitant — FDA Animal & Veterinary Adverse Event (ADE) Reports

Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-21. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Maropitant is a NK-1 antagonist antiemetic (Cerenia).

Total reports

Maropitant: 16284

Reports by species (top entries)

  • Dog 11527
  • Cat 3707
  • Human 205
  • Other 7
  • Rabbit 6
  • 3

Top reported reactions (VEDDRA terms, top entries)

  • Vomiting 3907
  • Lethargy (see also Central nervous system depression in 'Neurological') 2179
  • Anorexia 2075
  • Diarrhoea 1920
  • Death by euthanasia 1729
  • Death 1557
  • Lack of efficacy - NOS 1463
  • Not eating 1373
  • Lethargy (see also Central nervous system depression in Neurological) 1273
  • Elevated alanine aminotransferase (ALT) 1256

"Lack of efficacy" terms denote product-performance reports, not adverse reactions.

Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-21.json (openFDA animalandveterinary/event.json, pulled 2026-07-21).

Sources

  • openFDA animalandveterinary/event.json (FDA CVM adverse event reports), pulled 2026-07-21